Quarterly Activity Report and Appendix 4C for 31 Mar 2022

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 March 2022. The announcement highlights: MagSense® HER2 breast…


MagSense® HER2 Breast Cancer First-in-human Study Progress Update

Imagion Biosystems Limited (ASX: IBX) is pleased to provide an update on the progress of its first-in-human study for the MagSense® HER2 breast cancer imaging…


Quarterly Activity Report and Appendix 4C for 31 December 2021

Imagion has released the Quarterly Activity Report and Appendix 4C for the period ending on 31 December 2021. The announcement highlights a recap of the…


Application for quotation of +securities

The document "Application for quotation of +securities" was lodged with ASX on 6th January, 2022. Please click to review the full announcement at ASX.


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

The document "Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001" was lodged with ASX on 6th January, 2022. Please click to review the full…


Notification of Issue, Conversion of Payment up of Unquoted Equity Securities

The document "Notification of Issue, Conversion of Payment up of Unquoted Equity +Securities" was lodged with ASX on 16 December, 2021. Please click to review…


Remuneration Update and Employee Equity Incentives

The document "Remuneration Update and Employee Equity Incentives" was lodged with ASX on 16 December 2021. Please click to review the full announcement at ASX.


IBXO Options Exercise Complete

Imagion Biosystems is pleased to advise that it has now received the full $4.8 million from the exercise of all 96,706,395 listed options (IBXO) which had an…


Appendix 2A — Application for Quotation of +Securities

The following Appendix 2A was announced via ASX on 1 Dec 2021. Please click to review full announcement.  


Notice Pursuant to Section 708A(5)(e) of the Corporations Act 2001

The following cleansing notice was lodged with ASX on December 1, 2021: Imagion Biosystems Limited (ASX: IBX) (the Company) gives notice that, between 26…